Mineralys Therapeutics MLYS Balance Sheet (2022-2026)

NASDAQ MLYS
$24.48 -1.15 (-4.49%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Mineralys Therapeutics Quarterly Balance Sheet

Periods 18 quarters
Latest Jun 2026

Mineralys Therapeutics reported total assets of $667.85M and total liabilities of $116.94M for the quarter ended Jun 2026, up 98.9% year over year. This balance sheet covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 87.70M138.25M101.14M86.30M49.30M90.42M67.86M97.27M114.09M165.01M101.79M217.60M172.92M112.78M138.27M
Prepaid Assets 2.70M4.63M8.39M11.61M12.54M8.25M6.89M4.13M7.16M11.48M10.35M6.17M4.75M6.41M4.39M
Current Assets 112.81M275.27M269.49M265.38M249.10M346.82M318.00M267.73M205.35M354.51M335.27M599.80M661.39M652.47M665.80M
Non-Current Assets
Property, Plant & Equipment (Net) 0.05M0.04M0.07M0.05M0.04M0.02M0.01M0.04M0.03M0.03M
Long-Term Investments 31.12M21.68M12.13M2.48M
Other Non-Current Assets 1.63M0.04M0.05M0.05M0.05M0.38M0.45M0.45M0.50M0.40M0.43M0.14M0.38M0.36M2.02M
Non-Current Assets 1.63M31.16M21.73M12.18M2.53M0.43M0.49M0.52M0.55M0.43M0.46M0.15M0.42M0.39M2.05M
Assets 114.44M306.44M291.22M277.56M251.64M347.25M318.49M268.25M205.90M354.94M335.72M599.95M661.81M652.86M667.85M
Liabilities
Current Liabilities
Accounts Payables 1.91M2.39M2.20M5.57M0.60M4.26M1.71M3.11M0.48M0.37M3.16M1.12M2.02M1.12M1.07M
Payables 1.91M2.39M2.20M5.57M0.60M4.26M1.71M3.11M0.48M0.37M3.16M1.12M2.02M1.12M1.07M
Accumulated Expenses 6.16M8.17M4.01M7.97M9.88M14.94M26.69M28.21M14.17M13.01M19.01M22.40M13.10M13.60M18.25M
Total Current Liabilities 8.07M10.56M6.21M13.54M10.48M19.20M28.40M31.32M14.65M13.39M22.17M23.52M15.11M14.72M19.32M
Non-Current Liabilities
Non-Current Debt 97.62M
Preferred Stock Liabilities 40.99M158.64M158.64M158.64M
Total Liabilities 166.71M10.56M6.21M13.54M10.48M19.20M28.40M31.32M14.65M13.39M22.17M23.52M15.11M14.72M116.94M
Shareholder's Equity
Total Debt 97.62M
Common Equity -30.48M-36.93M-43.41M-52.27M295.88M285.01M264.01M241.15M328.05M290.10M236.93M191.26M341.56M313.55M576.43M646.69M638.14M550.92M
Liabilities and Shareholders Equity 114.44M306.44M291.22M277.56M251.64M347.25M318.49M268.25M205.90M354.94M335.72M599.95M661.81M652.86M667.85M
Retained Earnings -52.81M-65.42M-77.60M-100.32M-124.71M-156.22M-197.23M-253.60M-302.52M-344.73M-388.00M-424.94M-457.17M-496.51M-737.60M

Mineralys Therapeutics Balance Sheet API

Pull Mineralys Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MLYS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY